Estimation of Anti-SARS-CoV-2 IgM/IgG Seroprevalence Among Non-Vaccinated and Vaccinated University Students: A Cross-Sectional Egyptian Study

被引:0
|
作者
Taha, Ahmed E. [1 ,2 ]
Amer, Ibrahim [3 ]
El Sharawy, Shimaa [4 ]
Ghazy, Amany A. [1 ]
机构
[1] Jouf Univ, Coll Med, Dept Pathol, Microbiol & Immunol Unit, Sakaka 72388, Saudi Arabia
[2] Mansoura Univ, Fac Med, Med Microbiol & Immunol Dept, Mansoura 35516, Egypt
[3] Kafr Elsheikh Univ, Fac Med, Dept Hepatol Gastroenterol & Infect Dis, Kafr Al Sheikh 33516, Egypt
[4] Tanta Univ, Fac Med, Dept Trop Med & Infect Dis, Tanta 31527, Egypt
来源
VIRUSES-BASEL | 2025年 / 17卷 / 03期
关键词
COVID-19; healthy; immunization; SARS-CoV-2; serological testing; vaccines; viruses; IMMUNE-RESPONSE; COVID-19; OBESITY; ANTIBODIES;
D O I
10.3390/v17030378
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
It is essential to comprehend the humoral immune response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its vaccines to maximize the effectiveness of anti-SARSCoV-2 community immunization efforts. The aim of this cross-sectional study was to determine the seroprevalence of anti-SARS-CoV-2 IgM/IgG among newcomer students at Kafr Elsheikh University in Egypt, whether they had been vaccinated or not. Blood samples from 400 healthy newcomer students (200 non-vaccinated and 200 vaccinated) were evaluated for the presence of anti-SARS-CoV-2 IgM/IgG using colloidal gold immunochromatography lateral flow immunoassay cards, and then the results were confirmed by using specific ELISA tests. The prevalence of anti-SARS-CoV-2 antibodies among the participants (n = 400) was 56.3% for IgG and 13.3% for IgM. Regarding the non-vaccinated participants, 55.0% were females, the mean age was 18.2 years, and the mean BMI was 25.35. Regarding the vaccinated participants, 58.5% were females, the mean age was 18.1 years, and the mean BMI was 25.3. There were statistically non-significant correlations (p > 0.05) between gender, BMI, and each of IgM- or IgG-positivity in both vaccinated and non-vaccinated groups. In total, 41.5% and 48.5% of the anti-SARS-CoV-2 IgM-positive and anti-SARS-CoV-2 IgG-positive participants were non-vaccinated, respectively. Furthermore, 58.5% and 51.5% of the anti-SARS-CoV-2 IgM-positive and anti-SARS-CoV-2 IgG-positive participants were vaccinated, respectively. No statistically significant association (p > 0.05) in immunoglobulins positivity between the anti-SARS-CoV-2 non-vaccinated, and vaccinated groups. The anti-SARS-CoV-2 immunological response of nonsmokers, people who exercise regularly, and those who take vitamin supplements, eat a balanced diet, and use certain herbs is noteworthy. Among the vaccinated subjects, 96.6%, 25.0%, 31.9%, 45.7%, and 7.8% of the IgG-positive group, versus 97.2%, 60.6%, 64.2%, 52.3%, and 6.4% of the IgG-positive non-vaccinated group, were nonsmokers, exercisers, and those taking vitamin supplements, eating a balanced diet, and using herbs, respectively. Furthermore, 93.5%, 32.3%, 35.5%, 48.4%, and 6.5% of the IgM-positive vaccinated group, versus 100.0%, 63.6%, 81.8%, 45.5%, and 4.5% of the IgM-positive non-vaccinated participants, were nonsmokers, physical exercisers, vitamin supplement users, balanced eaters, and herbalists, respectively. Persons who are free from comorbidities, young, non-obese, non-smokers, engage in physical exercise, take vitamins, eat a balanced diet, and use certain immunostimulant herbal supplements, all have a strong anti-SARS-CoV-2 humoral immune response, even if they were not vaccinated. During pandemics, vaccination of this group should not be a priority to preserve vaccine doses for high-risk vulnerable people. Even if there is a lockdown during an anticipated future epidemic or pandemic, we should prioritize healthy eating and lifestyle choices, along with increasing physical activity.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study
    Beaumont, Adeline
    Durand, Cecile
    Ledrans, Martine
    Schwoebel, Valerie
    Noel, Harold
    Le Strat, Yann
    Diulius, Donatien
    Colombain, Lea
    Medus, Marie
    Gueudet, Philippe
    Mouly, Damien
    Aumaitre, Hugues
    BMJ OPEN, 2021, 11 (11):
  • [42] Prevalence of anti-SARS-CoV-2 antibody in hemodialysis facilities: a cross-sectional multicenter study from Madinah
    Housawi, Abdulrahman A.
    Qazi, Shazada Junaid S.
    Jan, Abdulhalem A.
    Osman, Rashid A.
    Alshamrani, Mashil M.
    AlFaadhel, Talal A.
    AlHejaili, Fayez F.
    Al-Tawfiq, Jaffar A.
    Wafa, Ahmed A.
    Hamza, Abdulmageed E.
    Hassan, Moustafa A.
    Alharbi, Suliman A.
    Albasheer, Hamza
    Almohmmdi, Majed M.
    Alsisi, Salem A.
    Mankowski, Michal
    Van de Klundert, Joris
    Alhelal, Amal M.
    Sala, Fatima H.
    Kheyami, Ali
    Alhomayeed, Bader A.
    ANNALS OF SAUDI MEDICINE, 2022, 42 (04) : 229 - 235
  • [43] Seroprevalence of anti-SARS-CoV-2 antibodies and risk of viral exposure among healthcare workers in the South Kivu province, eastern Democratic Republic of the Congo: a cross-sectional study
    Chasinga, Tshass B.
    Cikwanine, Jean-Paul Buhendwa
    Kribi, Sarah
    Yoyu, Jonathan Tunangoya
    Hofmann, Natalie
    Grossegesse, Marica
    Nitsche, Andreas
    Tomczyk, Sara
    Vietor, Ann C.
    Leendertz, Fabian H.
    Eckmanns, Tim
    Kusinza, Aline B.
    Munguakonkwa, Eric
    Kalk, Andreas
    Raha, Maroyi
    Kambale, Nelson S.
    Ayagirwe, Rodrigue B.
    Schubert, Grit
    Mukwege, Denis
    BMJ OPEN, 2024, 14 (01):
  • [44] Anti-SARS-CoV-2 antibody among SARS-CoV-2 vaccinated vs post-infected blood donors in a tertiary hospital, Bangkok, Thailand
    Permpikul, Parichart
    Tongyoo, Surat
    Chaimayo, Chutikarn
    Kanpai, Prapan
    Virat, Jitmanee
    Virat, Sutasinee
    Chuchaaim, Jaratsri
    Thongput, Anchalee
    Bhatnagar, Sonu
    PLOS ONE, 2023, 18 (05):
  • [45] Assessment on anti-SARS-CoV-2 receptor-binding domain antibodies among CoronaVac-vaccinated Indonesian adults
    Jo, Juandy
    Sanjaya, Astia
    Pinontoan, Reinhard
    Aruan, Maroloan
    Wahyuni, Rury Mega
    Viktaria, Venansi
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2022, 11 (01) : 116 - 120
  • [46] Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study
    Ebinger, Joseph E.
    Botwin, Gregory J.
    Albert, Christine M.
    Alotaibi, Mona
    Arditi, Moshe
    Berg, Anders H.
    Binek, Aleksandra
    Botting, Patrick
    Fert-Bober, Justyna
    Figueiredo, Jane C.
    Grein, Jonathan D.
    Hasan, Wohaib
    Henglin, Mir
    Hussain, Shehnaz K.
    Jain, Mohit
    Joung, Sandy
    Karin, Michael
    Kim, Elizabeth H.
    Li, Dalin
    Liu, Yunxian
    Luong, Eric
    McGovern, Dermot P. B.
    Merchant, Akil
    Merin, Noah
    Miles, Peggy B.
    Minissian, Margo
    Nguyen, Trevor Trung
    Raedschelders, Koen
    Rashid, Mohamad A.
    Riera, Celine E.
    Riggs, Richard, V
    Sharma, Sonia
    Sternbach, Sarah
    Sun, Nancy
    Tourtellotte, Warren G.
    Van Eyk, Jennifer E.
    Sobhani, Kimia
    Braun, Jonathan G.
    Cheng, Susan
    BMJ OPEN, 2021, 11 (02): : e043584
  • [47] Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
    Taher, Watheq Thabet
    Bawazir, Amen A.
    Sallam, Talal A.
    Alsurimi, Khaled
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [48] Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
    Watheq Thabet Taher
    Amen A. Bawazir
    Talal A. Sallam
    Khaled Alsurimi
    BMC Infectious Diseases, 23
  • [49] Sensitivities of a Rapid Test Versus an ELISA Kit for Detecting Anti-SARS-CoV-2 IgM/IgG in Sera from an Egyptian Cohort
    Bahgat, Mahmoud Mohamed
    Nasraa, Mohamed Hassan
    Nadeem, Rola
    Amer, Khaled
    Hassan, Wael A.
    Elgarhy, Fadya M.
    Reda, Salem
    Fasemore, Akinyemi M.
    Foerstner, Konrad U.
    Abd-Elshafy, Dina Nadeem
    CURRENT MICROBIOLOGY, 2024, 81 (01)
  • [50] Sensitivities of a Rapid Test Versus an ELISA Kit for Detecting Anti-SARS-CoV-2 IgM/IgG in Sera from an Egyptian Cohort
    Mahmoud Mohamed Bahgat
    Mohamed Hassan Nasraa
    Rola Nadeem
    Khaled Amer
    Wael A. Hassan
    Fadya M. ELGarhy
    Salem Reda
    Akinyemi M. Fasemore
    Konrad U. Förstner
    Dina Nadeem Abd-Elshafy
    Current Microbiology, 2024, 81